March 2018 – Bariatric News

A drug-free approach might be the best treatment we have for America’s most ubiquitous lifestyle disease.

Source: Is Keto the Cure for Type II Diabetes?

Using the preoperative psychological evaluation to determine psychosocial risk factors for CPAP nonadherence among bariatric surgery candidates November 8, 2019

Obstructive sleep apnea (OSA) is prevalent among bariatric surgery candidates and is associated with numerous adverse health conditions, both pre- and postoperatively. Continuous positive airway pressure therapy (CPAP) is the first-line treatment for OSA, but it requires significant behavioral changes. As such, CPAP adherence is a significant problem in OSA treatment. Information from the preoperative […]

Katy W. Martin-Fernandez, Leslie J. Heinberg, Yossef S. Ben-Porath

Impact of serum uric acid on renal function after bariatric surgery: A retrospective study November 7, 2019

Despite known negative association between serum uric acid level (SUA) and renal function, this correlation in patients following bariatric surgery (BS) remains unknown.

Kuo-Chuan Hung, Chun-Ning Ho, I-Wen Chen, Chin-Chen Chu, Cheuk-Kwan Sun, Tien-Chou Soong

Effect of Intraperitoneal Bupivacaine on Postoperative Pain in Laparoscopic Bariatric Surgeries November 7, 2019

Postoperative pain has many adverse effects and, if not properly controlled, it may lead to a wide range of complications. Opioids, as frequently used drugs for pain control, have some serious respiratory and gastrointestinal complications especially in obese patients.

Saeed Safari, Faranak Rokhtabnak, Soudabeh Djalali Motlagh, Maryam Ghanbari Garkani, Alireza Pournajafian

Is it Worth it? Determining the Health Benefits of Sleeve Gastrectomy in Patients with a Body Mass Index Less than 35 kg/m2 November 7, 2019

Criteria for undergoing sleeve gastrectomy (SG) is restricted among patients with a body mass index (BMI) < 35 kg/m2.

Oliver A. Varban, Aaron J. Bonham, Jonathan F. Finks, Dana A. Telem, Nabeel R. Obeid, Amir A. Ghaferi

A Rodent Model of Partial Intestinal Diversion: A Novel Metabolic Operation November 7, 2019

Metabolic surgery is safe and the most effective therapy for obesity and its comorbidities. New procedures may allow for better tailoring of metabolic surgery to the individual patient.

Rafael Alvarez, Darleen A. Sandoval, Randy J. Seeley

Month: March 2018

4 reasons you’re always hungry

Is Keto the Cure for Type II Diabetes?